To examine whether fibroblast activation in ovarian tumors is related to lower tumor-infiltrating lymphocyte counts in tumor parenchyma, we evaluated two different fibroblast activation markers, FAP and α-SMA. The gene discussed is ACTA1; the disease is neoplasm.